|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Healthcare services | |||||
| Healthcare products | |||||
| Insurance contracts | |||||
| Revenue | |||||
| Costs of revenue: | |||||
| Healthcare services | |||||
| Healthcare products | |||||
| Insurance contracts | |||||
| Costs of revenue | |||||
| Operating (income) expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Income from equity method investees | |||||
| Other operating income | |||||
| Other operating expense | |||||
| Operating income | |||||
| Other (income) expense: | |||||
| Interest income | |||||
| Interest expense | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net income attributable to shareholders of FME AG | |||||
| Basic earnings per share | |||||
| Diluted earnings per share | |||||
Loading...
